Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus

<table>The docked conformation of compound 11 with the receptor CDK5/p25 (PDB: 3O0G). Compound 11 is indicated by red color while the most active site of the CDK5 receptor is shown with yellow color.</table>

International Journal of Endocrinology

fig11

Figure 11

Figure 11: Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus 